机构:[1]Department of Surgery, School of Clinical Medicine, Dali University, Dali, Yunnan 671000, People's Republic of China.[2]The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, People's Republic of China.[3]Department of Human Anatomy, School of Basic Medical Sciences, Dali University, Dali, Yunnan 671000, People's Republic of China.
Initial Scientific Research
Fund of Doctor at Dali University (KYBS2018018).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|3 区医学
小类|3 区生物工程与应用微生物4 区肿瘤学
最新[2023]版:
大类|4 区医学
小类|3 区生物工程与应用微生物4 区肿瘤学
第一作者:
第一作者机构:[1]Department of Surgery, School of Clinical Medicine, Dali University, Dali, Yunnan 671000, People's Republic of China.[*1]Department of Surgery, School of Clinical Medicine, Dali University, Xue-Ren Road, Xia Guang District, Dali, Yunnan 671000, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Surgery, School of Clinical Medicine, Dali University, Dali, Yunnan 671000, People's Republic of China.[*1]Department of Surgery, School of Clinical Medicine, Dali University, Xue-Ren Road, Xia Guang District, Dali, Yunnan 671000, People’s Republic of China
推荐引用方式(GB/T 7714):
Wang Jing,Wang Ning,Zhao Wei-Dong,et al.RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma[J].OncoTargets and therapy.2019,12:11221-11229.doi:10.2147/OTT.S225532.
APA:
Wang Jing,Wang Ning,Zhao Wei-Dong,Zhao Li-Xian,Jing Yong-Guang...&Li Jun.(2019).RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma.OncoTargets and therapy,12,
MLA:
Wang Jing,et al."RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma".OncoTargets and therapy 12.(2019):11221-11229